Page 33 - A9Rc19d2z_zddyc4_fc0.tmp
P. 33

*Reducing land degradation and carbon loss from   Valuing whole genome sequencing to improve diagnosis
                  Ethiopia’s solid to strengthen livelihoods and resilience   of rare disorders: a health economic perspective
                  (RALENTIR)                                     Investigators: Ryan, M., McKenzie, L., Heidenreich, S.,
                  Investigators: Phimister, E. (Business School, University of   Moran, B. (HERU); Miedzybrodzka, Z., Mennie, L. (Applied
                  Aberdeen); Watson, V. (HERU); Smith, J.U., Hallett, P. (Institute   Medicine, University of Aberdeen); Aitman, T. (University of
                  of Biological and Environmental Science, University of   Edinburgh).
                  Aberdeen); Mekuria, W., Haile, A., Tekle, A. (Nile Basin & East   Source of Funding: Scottish Genomics Partnership and Chief
                  Africa Office, International Water Management Institute);   Scientist Office (CSO) CORE.
                  Ameda, T.T., Lemma Argaw, T. (Hawassa University); Byg,   What can eye tracking tell us about decision-making
                  A. (James Hutton Institute); Edo., G. (Southern Agricultural   heuristics in discrete choice experiments?
                  Research Institute); Fischer, A. (Swedish University of   Investigators: Ryan, M. (HERU); Hermens, F. (University of
                  Agricultural Science).                         Lincoln); Krucien, N. (Evidera).
                  Source of Funding: Global Challenges Research Fund,   Source of Funding: University of Aberdeen and Chief
                  Economic and Social Research Council and Chief Scientist   Scientist Office (CSO) CORE.
                  Office (CSO) CORE.
                                                                 Willingness to pay for relief from diseases and symptoms
                  Supporting shared decision making in advanced breast   Investigators: Laufey, T. (University of Iceland); McNamee, P.
                  cancer: what matters to patients in an era of personalised   (HERU).
                  care                                           Source of Funding: The Icelandic Research Fund 2018 and
                  Investigators: Hall, P. (University of Edinburgh); Ryan,   the University of Aberdeen.
                  M. (HERU); Gray, E., University of Edinburgh); O’Hare, S-M.
                  (Edinburgh Breast Unit) and Krucien, N. (Evidera).
                  Source of Funding: Breast Cancer Institute and Chief Scientist
                  Office (CSO) CORE.

                  Thriving not surviving following a breast cancer
                  diagnosis: what can time allocation tell us? (PhD)
                  Investigators: Gao, N. (PhD Student), Ryan, M. (HERU);
                  Norman, R., Robinson, S. (Curtin University, Western Australia);
                  Krucien, N. (Evidera).
                  Source of Funding: NHS Grampian (NHSG) via University of
                  Aberdeen Development Trust, Chief Scientist Office (CSO)
                  CORE and University of Aberdeen.

                  To pay or not to pay? The impact of the price attribute in
                  choice experiments
                  Investigators: Ryan, M., Genie, M. (HERU); Krucien, N.
                  (Evidera).
                  Source of Funding: University of Aberdeen and Chief
                  Scientist Office (CSO) CORE.

                  *Valuing baby boxes: what’s important to parents?
                  Investigators: Skea, Z., Locock, L. (Health Services Research
                  Unit, (HSRU), University of Aberdeen); Ryan, M. (HERU);
                  Morgan, H. (Institute of Applied Health Sciences, University
                  of Aberdeen); Black, M. (Aberdeen Centre for Women’s Health
                  Research, University of Aberdeen).
                  Source of Funding: NHS Grampian Endowments and Chief
                  Scientist Office (CSO) CORE.






            HERU ANNUAL REPORT 2019                                                                             33
   28   29   30   31   32   33   34   35   36   37   38